The first steps in insulin action are binding of insulin to its receptor and activation of the insulin receptor kinase. As there is indirect evidence that further signal transduction might involve a guanine-nucleotide-binding protein (G-protein), we studied whether insulin modulates GTP binding to plasma membrane proteins of fat cells and skeletal muscle. We found that insulin rapidly increased (30 s) binding of guanosine 5'-[y-thio]triphosphate (GTP[S]) in a dose dependent manner (0.03-2.0 nM). This effect was not altered by pertussis toxin, but it was abolished by cholera toxin treatment of fat cells. Scatchard analysis of the binding data showed that the increased GTP [S] binding is due to a decrease in the Kd for GTP from 100 nm to 50 nm. Furthermore, binding of GTP to these plasma membranes inhibited both the binding of 1251-insulin to the insulin receptor and the stimulation of the insulin receptor kinase, suggesting a feedback interaction between the insulin-stimulated GTP-binding site and the insulin receptor. In order to identify this insulin-stimulated GTP-binding site, plasma membranes were labelled with the photoreactive GTP analogue [a-32P]GTP y-azidoanilide. We found that insulin selectively stimulated GTP binding to a 40 kDa protein. In conclusion, in plasma membranes of fat cells and skeletal muscle, the insulin receptor interacts with a 40 kDa GTP-binding site. We speculate that this 40 kDa GTP-binding site might be a G-protein which is involved in insulin signal transmission.
INTRODUCTION
The mechanism of cellular insulin action is not understood in detail. The early steps of insulin signal transduction involve insulin binding to the a-subunit of the receptor at the cell surface and activation of the tyrosine kinase located in the cytoplasmic part of the receptor fl-subunit [1] . An intramolecular autophosphorylation cascade within the receptor kinase amplifies the insulin signal [2] . The further signal transduction to the metabolic machinery of the target cell may then occur through tyrosine phosphorylation of other substrates [3, 4] or direct noncovalent interaction of the autophosphorylated receptor with regulatory proteins. Among possible candidates for these regulatory proteins are the guanine-nucleotide-binding proteins (G-proteins) . A direct effect of insulin on GTP binding to one of these proteins has not been shown to date; however, there is ample indirect evidence for a role of G-proteins in cellular insulin action. There are several reports which have shown that insulin alters the ADP-ribosylation of G-proteins by pertussis toxin [5] [6] [7] . Further, a modulation of G-protein expression was demonstrated in insulin-deficient streptozotocin-diabetes [8] . There is also evidence for a role of G-proteins in insulin signalling in glucose transport, as the effect of insulin on intrinsic glucose carrier activity can be mimicked by aluminium fluoride [9] , which is a known stimulator of G-proteins. A role for G-proteins in insulin signalling was furthermore suggested by the observations that G-proteins serve in a cell-free system as substrates for the purified insulin receptor kinase [10] [11] [12] and that G-proteins are able to modulate insulin receptor kinase activity [13] . This led to the speculation that a signal transfer from the insulin receptor to G-proteins might occur through phosphorylation of G-proteins at tyrosine residues [10] [11] [12] . However, other studies suggest that tyrosine phosphorylation of G-proteins is only an in vitro phenomenon, which is not found in intact cells [4, 7] . On the other hand, it is particularly interesting that G-proteins exhibit in the cell-free system a remarkably high affinity for the autophosphorylated receptor [11] . Therefore a direct non-covalent interaction of a G-protein with the autophosphorylated receptor could possibly mediate a signal transfer from the receptor to a G-protein. We followed by hypothesis that receptor autophosphorylation might be important for such an insulin effect, and studied the binding of guanosine 5'-[y-thio]triphosphate [GTP[S] ) to plasma membranes under experimental conditions which allow the insulin receptor kinase to undergo insulinstimulated autophosphorylation. Under these conditions we found a direct stimulatory effect of insulin on GTP binding.
EXPERIMENTAL Materials
Pig '251-insulin (labelled on TyrAL4; 2200 Ci/mmol), [y-32p]_ NAD (800 Ci/mmol), GTP[35S] (800-1500 Ci/mmol) and [y-32P]ATP (3000 Ci/mmol) were from New England Nuclear (Dreieich, Germany). Aprotinin, phenylmethanesulphonyl fluoride, poly(Glu4: Tyr,), leupeptin, pepstatin, benzamidine, bacitracin, leucine, a 5'-nueleotidase kit, cholera toxin and pertussis toxin were from Sigma (Munich, Germany). Triton X-100, all reagents for SDS/PAGE and the protein assay were from Bio-Rad (Munich, Germany). GTP and GTP[S] were obtained from Boehringer. N-(3-Dimethylaminopropyl)-N'-ethylcarbodi-imide hydrochloride was purchased from Merck; Mops and 4-azidoanilline sulphate were from Serva. All other substances and reagents were of the highest grade commercially available. For autoradiography, X-Omat AR5 diagnostic film was used (Kodak, Rochester, NY, U.S.A.).
Binding of GTPIS]
Plasma membrane fractions were prepared as described previously [9] . Reproducibility of the fractionation procedure was M. Kellerer and others assessed by measuring the specific 5'-nucleotidase activity in the plasma membrane fraction. [32PJGTP azidoanilide labelling of proteins from fat cell membranes and skeletal muscle [a-32P]GTP y-azidoanilide was prepared as described [14] . Fat cell and skeletal muscle membranes (40,g of protein) were preincubated for 5 min without or with insulin (2 nM) in the presence of Mn2+ and ATP.
[32P]GTP y-azidonanilide (3 UM) was then added for 5 min at 30°C in the dark. Covalent coupling was then initiated by u.v. irradiation for 3 min. To determine non-specific labelling, an excess of 10 uM unlabelled GTP[S] was added. Membrane proteins were alkylated with N-ethylmaleimide according to Evans et al. [15] and applied to SDS/PAGE. The gel was exposed to Kodak X-Omat film. Labelled bands were then cut from the gel and counted for radioactivity in a scintillation counter.
Insulin binding to plasma membranes
Plasma membranes were incubated with 1251-insulin (0.03 nM) and various concentrations of unlabelled insulin for 45 min at 22°C in a medium containing 150 mM-NaCl and 25 mM-Hepes, pH 7.4. Separation of the free and receptor-bound insulin was then performed by centrifugation through dinonyl phthalate.
Determination of insulin receptor kinase activity in vitro and in vivo Partially purified insulin receptors were prepared and phosphorylated in vitro as described [16] . The activation of the receptor kinase in plasma membranes was assessed by a modification of the method described for intact cells [17] . Briefly, fat cell plasma membranes were stimulated with insulin and insulin receptors were then purified as described [16] , but in the presence of vanadate (1 mM). Kinase activity was measured with poly(Glu4:Tyr,) as substrate, as described in [16] .
ADP-ribosylation
ADP-ribosylation of fat cell membranes was carried out as described [18] . Briefly, about 30 ,ug of plasma membranes was preincubated in the presence of insulin (2 nM) and MnCl2 (10 mM) or GTP[S] (1 /,zM), or neither of these, for 30 min at 32°C before ribosylation. Subsequently, ADP-ribosylation was carried out either with pertussis toxin or with cholera toxin. The reaction mixture for cholera-toxin-catalysed ribosylation contained NAD+ (10 /zM), [32P]NAD+ (5 X 106 c.p.m.), ADP-ribose (50 mM), thymidine (10 mM), ATP (1 mM), GTP (0.1 mM), EDTA (1 mM), MgCl2 (10mM), Tris/HCl (25 mM), dithiothreitol (1.66 mM) and cholera toxin (100,ug/ml) in phosphate buffer (300mM). The reaction mixture for pertussis-toxin-catalysed ribosylation contained 10 ,ug of pertussis toxin/ml and the same compounds as described for cholera toxin, but without phosphate buffer, ADP-ribose and MgCl2. Incubations were carried out at 32°C for 40 min and stopped by addition of 1 ml of ice-cold 20 % (v/v) trichloroacetic acid. After 20 min on ice, membranes were centrifuged at 9000 g for 10 min at 4 'C. The supernatants were discarded and the pellets were washed with 2 x 1 ml of diethyl ether. The membranes were dissolved in 30 ,1 of dithiothreitol (50 mM) and 5 % SDS before addition of 30 ,1 of Laemmli sample buffer [19] . The samples were subjected to SDS/PAGE without heating on a 10% linear polyacrylamide gel. The gels were dried and exposed to Kodak X-Omat film.
RESULTS

Effect of insufin on binding of GTPISI to plasma membranes
Hormone receptors which couple to G-proteins increase the ability of the a-subunit of the G-proteins to bind GTP [20] . Attempts to show an analogous effect for insulin have not been previously successful. Following the hypothesis that an insulin effect on a G-protein requires experimental conditions that allow the autophosphorylation of the insulin receptor kinase, we studied the properties of the binding of GTP[35S] to plasma membranes of fat cells under conditions where the fat cell receptor kinase may become activated [21] , i.e. in the presence of Mn2+ and ATP. Table 1 shows that in the absence of Mn2+, in the presence or the absence of ATP, no insulin effect was detectable. In contrast, in the presence of Mn2+ plus ATP a significant stimulatory insulin effect was observed, whereas the effect with ATP alone was not significant. Therefore manganese and ATP were included in all further experiments. Fig. 1 shows the association kinetics of GTP [S] binding to isolated fat cell membranes. The bottom curve shows the rate of non-specific binding, which had to be subtracted from the two upper curves to obtain specific binding values. The equilibrium of specific binding was reached after 10 min. Insulin stimulated rapidly (within 30 s) the rate of association and increased equilibrium binding. Half-maximal association occurred within 2 min in the absence of insulin; in the presence of insulin, half-maximal association was reached within 1 min. Insulin increased the equilibrium binding in fat cell membranes by 54+17 % (mean + S.E.M.; n = 10, P < 0.005). The same effect can be shown with skeletal muscle membranes (52 + 23 %; n = 5, P < 0.005). To determine the dose-response relationship of the effect of insulin on the binding of GTP [S] , membranes were incubated with increasing concentrations of insulin (Fig. 2) . The insulin effect was detectable at concentrations above 0.06 nm and reached its maximum at 2 nm. Thus this insulin effect had similar dose-response characteristics to those of other cellular insulin effects, such as the stimulation of glucose transport [9] . If fat cells were pretreated with pertussis toxin before preparation of membranes, no influence on the insulin effect was detected (Fig.   2 ). In contrast, pretreatment with cholera toxin abolished the insulin effect (Fig. 2) . To determine whether the insulin effect on equilibrium binding is due to a modulation of the number or the affinity of GTP-binding sites, we performed displacement studies with increasing concentrations of unlabelled GTP[S]. Fig. 3 shows these data presented as a Scatchard plot. There was no effect of insulin on the number of GTP exists in the plasma membranes of fat cells which is activated by the insulin receptor but which is also able to inhibit insulin receptor functions, possibly by a feedback mechanism. To test whether this reverse GTP[S] effect is also cholera-toxin-sensitive, we performed the experiments described above in membranes from fat cells treated with cholera toxin. Table 3 shows that the reverse GTP effect is indeed lost after cholera toxin treatment. Membrane labelling with 11_-32PIGTP y-azidoanilide ADP-ribosylation of fat cell membranes with cholera toxin and pertussis toxin In order to test whether this protein might be a substrate for cholera toxin or pertussis toxin, we studied the effect of insulin on ADP-ribosylation of fat cell membranes. A pattern similar to that described earlier [23] for rat adipocyte plasma membranes was found. Fig. 6 shows with pertussis toxin a band of approx. 41 kDa, most likely representing the labelling of G,a [23] , whereas cholera toxin induced the ADP-ribosylation of bands at approx. 44 48 kDa which were previously identified as G.ax [23] . ribosylation seen on the autoradiogram after treatment with insulin was not statistically significant (% of basal 32p incorporation: 44 kDa band, 90.1 + 20.6 %; 48 kDa band, 84.2 + 21.8 %; n = 4). In particular, there was in four separate experiments no cholera-toxin-dependent band detectable around 40 kDa after short time exposures of the films. On overexposure of the films it could not be excluded that there existed a very faint band around 40 kDa; however, at least with the present experimental design, the existence of a cholera-toxin-ribosylated protein at 40 kDa cannot be demonstrated. There are two possible explanations for these results. First, the 40 kDa band represents a minor protein compared with other GTP-binding proteins; however, the strong labelling with the [32P]GTP y-azidoanilide argues against this explanation. Secondly, the suppression of the forward and reverse interactions between the insulin receptor and the 40 kDa protein by cholera toxin might not be due to an ADP-ribosylation of this protein by cholera toxin, but rather may reflect a direct effect of cholera toxin on the receptor. Such an effect was recently described by others [24] .
DISCUSSION
Physiological concentrations of insulin stimulate GTP binding to plasma membranes with a time course similar to those of other rapid cellular insulin effects. The forward effect from the insulin receptor to a GTP-binding site is pertussis-toxin-insensitive but cholera-toxin-sensitive. A reverse effect from a GTP-binding site to the insulin receptor, i.e. the inhibition of receptor binding and kinase activation through GTP binding to plasma membranes, can also be demonstrated. The labelling experiments showed that the observed GTP binding probably occurs at a 40 kDa membrane protein. In summary, the interaction of the insulin receptor with the GTP-binding site follows classical patterns of hormone receptor and G-protein interaction [25] [26] [27] . Therefore we speculate that this 40 kDa protein might represent a specific G-protein which is involved in insulin signal transmission. At present the data do not allow us to identify the nature of this insulindependent G-protein. The molecular mass of a G-protein that is believed to be important in insulin action is 25 kDa [6] , clearly separating this putative Gins from the GTP-binding protein found here. On the other hand, the molecular mass of the protein described here is close to that of Gia [22, 28] , Goa [22, 28] , GCtal [29, 30] and Gta2 [31] and another, insulin-receptor-associated, but as yet unidentified, G-protein [32] . However, the difference in the susceptibility to pertussis and cholera toxins argues against these possible candidates. Further studies with specific antibodies are required to evaluate if this insulin-dependent G-protein is identical with one of those proteins. Concerning the role of this G-protein in insulin action, an interaction with phospholipase seems possible. There is increasing evidence that some insulin effects involve the activation of phospholipase C [33, 34] and the release of inositol phosphate oligosaccharides from membrane glycolipids [35, 36] . Further studies are needed to evaluate whether this insulin-dependent G-protein could serve as a link between the receptor and these phospholipases.
